What is Precigen's R&D?

Precigen (PGEN) reported R&D of $5.64M in Q1 2026.

How has Precigen's R&D changed year-over-year?

Precigen's R&D decreased by 46.2% year-over-year, from $10.48M to $5.64M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Precigen PGEN R&D

R&D at other companies

Bristol-Myers SquibbBMY

$2.65B+17.4%

Regeneron PharmaceuticalsREGN

$1.54B+16.3%

Viridian Therapeutics, Inc.VRDN

$77.63M+1.0%

Agios PharmaceuticalsAGIO

$81.15M+11.6%

Apogee Therapeutics, Inc.APGE

$60.82M+31.1%

Arrowhead ResearchARWR

$173.25M+30.2%

Other financials

Income statement

See full

Revenue$23.3M+1,634%

Operating income-$6.0M+73.5%

Net income-$7.9M+85.4%

EPS (diluted)-$0.02+88.9%

Balance sheet

See full

Cash & equivalents$7.5M+23.5%

Total debt$98.3M+1,714%

Total equity$20.2M+244%

Total assets$138.6M+7.6%

Cash flow

See full

Operating cash flow-$43.8M-168%

CapEx$258.0K-58.5%

Free cash flow-$44.1M-160%

Valuation

See full

Market cap$1.91B+213%

Enterprise value$2B+234%

P/S72×—

Profitability

See full

Gross margin83.6%—

Operating margin-2,890.9%—

Net margin-3,656%—

FCF margin-1,756.5%—

Returns & leverage

See full

Return on equity-843.6%-1,103pp

Debt / equity4.9×—

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Precigen's R&D?: Precigen (PGEN) reported R&D of $5.64M in Q1 2026.
How has Precigen's R&D changed year-over-year?: Precigen's R&D decreased by 46.2% year-over-year, from $10.48M to $5.64M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.